Chimaeric Antigen Receptor T-Cell Therapy NewsLatest News On Chimaeric Antigen Receptor T-Cell Therapy CAR-T Cells and Beyond: Breakthroughs and Challenges Ahead12/16/2024 6:25 AM Early Success Seen With CAR T-Cell Therapy for Systemic Sclerosis12/13/2024 6:16 AM Epcore NHL-1 Update: Treatment Effective Before CAR T12/9/2024 12:43 AM Can New Therapies Redefine Psoriasis Management?11/27/2024 5:11 AM ASH 2024 Myeloma Studies: My Top 10 Picks11/27/2024 1:48 AM FDA Approved Obe-cel, a Novel CD19 CAR T Product for ALL11/8/2024 4:54 PM Outpatient CAR T: Safe, Effective, Accessible11/1/2024 7:22 AM Multi-Refractory MM: After Immunotherapy, What?10/25/2024 7:49 AM Lymphoma Debate: CAR T Not a Clear Winner10/24/2024 9:09 AM Many Hurdles Exist to Treating Lung Cancer With CAR T Cells10/10/2024 7:41 AM CARTITUDE-4 Update: Cilta-Cel Improves OS in R/R MM10/3/2024 6:30 AM FDA Approves First Engineered Cell Therapy for a Solid Tumor8/2/2024 12:16 PM LBCL: CAR T Benefits Both Young and Old7/30/2024 1:07 AM Dual CAR-T Therapies Are Becoming More Established6/26/2024 1:29 AM DLBCL: Glofitamab Plus Chemo Boosts Survival6/21/2024 11:41 AM CAR T for B-ALL: Game Changer For Young Patients?6/7/2024 4:34 AM India Has Low-Cost CAR T-Cell Therapy: Can US Follow Suit?6/6/2024 12:59 PM Timing Is Everything: CAR T for Follicular Lymphoma4/25/2024 5:32 AM ALL: Which Life-Saving Tx Is Best?4/15/2024 6:50 AM Abecma Approved for Earlier Lines in Relapsed/Refractory Multiple Myeloma4/8/2024 1:35 PM
